The artificial heart : prototypes, policies, and patients

著者

書誌事項

The artificial heart : prototypes, policies, and patients

Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute, Division of Health Care Services, Institute of Medicine ; John R. Hogness and Malin VanAntwerp, editors

National Academy Press, 1991

大学図書館所蔵 件 / 全4件

この図書・雑誌をさがす

注記

"Support for this project was provided by the National Institutes of Health, National Heart, Lung, and Blood Institute, pursuant to contract no. NO1-HO-09008"--T.p. verso

Includes bibliographical references and index

内容説明・目次

内容説明

A significant medical event is expected in 1992: the first human use of a fully implantable, long-term cardiac assist device. This timely volume reviews the artificial heart program-and in particular, the National Institutes of Health's major investment-raising important questions. The volume includes: Consideration of the artificial heart versus heart transplantation and other approaches to treating end-stage heart disease, keeping in mind the different outcomes and costs of these treatments. A look at human issues, including the number of people who may require the artificial heart, patient quality of life, and other ethical and societal questions. Examination of how this technology's use can be targeted most appropriately. Attention to achieving access to this technology for all those who can benefit from it. The committee also offers three mechanisms to aid in allocating research and development funds. Table of Contents Front Matter Executive Summary 1. The Artificial Heart Program: Current Status and History 2. Total Artificial Hearts: Technological Potential and Research and Development Costs 3. Decisions for Future Research and Development 4. Clinical Effectiveness and Need for Long-Term Circulatory Support 5. Quality of Life and Mechanical Circulatory Support Systems 6. Cost-Effectiveness Analysis 7. The Appropriate Use of Technology 8. Ethical and Societal Issues 9. Roles of Government and Industry in Medical Technology Research, Development and Use 10. Conclusions and Recommendations Appendix A: History and Methods of This Evaluation Appendix B: A Chronology of the National Heart, Lung, and Blood Institute Artificial Heart Program and Related Events Appendix C: Technological Opportunities and Barriers in the Development of Mechanical Circulatory Support Systems Appendix D: Epidemiology of End-Stage Heart Disease Appendix E: Assessing the Cost-Effectiveness of the Development and Use of the Total Artificial Heart Glossary Index

目次

  • 1 Front Matter
  • 2 Executive Summary
  • 3 1. The Artificial Heart Program: Current Status and History
  • 4 2. Total Artificial Hearts: Technological Potential and Research and Development Costs
  • 5 3. Decisions for Future Research and Development
  • 6 4. Clinical Effectiveness and Need for Long-Term Circulatory Support
  • 7 5. Quality of Life and Mechanical Circulatory Support Systems
  • 8 6. Cost-Effectiveness Analysis
  • 9 7. The Appropriate Use of Technology
  • 10 8. Ethical and Societal Issues
  • 11 9. Roles of Government and Industry in Medical Technology Research, Development and Use
  • 12 10. Conclusions and Recommendations
  • 13 Appendix A: History and Methods of This Evaluation
  • 14 Appendix B: A Chronology of the National Heart, Lung, and Blood Institute Artificial Heart Program and Related Events
  • 15 Appendix C: Technological Opportunities and Barriers in the Development of Mechanical Circulatory Support Systems
  • 16 Appendix D: Epidemiology of End-Stage Heart Disease
  • 17 Appendix E: Assessing the Cost-Effectiveness of the Development and Use of the Total Artificial Heart
  • 18 Glossary
  • 19 Index

「Nielsen BookData」 より

詳細情報

ページトップへ